| Filed On | Filing |
|---|---|
| 09 Jun 2026 |
8-K/A: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more
NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UN... |
| 10 Mar 2023 |
8-K/A: Financial Statements and Exhibits
On May 13, 2022, 22nd Century Group, Inc. (the “Company”) entered into a Reorganization and Acquisition Agreement (the “Reorganization Agreement”) with GVB Biopharma (“GVB”). Under the terms of the Reorganization Agreement, the Company a... |
| 02 Sep 2022 |
8-K/A: Financial Statements and Exhibits
On May 13, 2022, 22nd Century Group, Inc. (the “Company”) entered into a Reorganization and Acquisition Agreement (the “Reorganization Agreement”) with GVB Biopharma (“GVB”). Under the terms of the Reorganization Agreement, the Company a... |
| 20 Jul 2022 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying combined consolidated balance sheets of GVB Biopharma (a Nevada corporation) and subsidiaries (the “Company”) as of December 31, 2021 and 2020, and the related combined consolidated statements of operatio... |
| 23 Mar 2011 | 8-K/A: Completion of Acquisition or Disposition of Assets; Amendments to Articles/Bylaws; Change in Fiscal Year |
| 19 Jun 2008 | 8-K/A: Departure/Election of Directors or Officers; Compensation; Other Events |
Loading...
